Healthcare / Medical Care FacilitiesNSE
$108.18
+0.27 (+0.25%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-21.3M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
40/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.2B
P/E
349.0x
↑EV/EBITDA
50.8x
↑ROE
0.1%
↓Gross Margin
48.7%
↑Debt/Equity
0.26
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+5.3%
FCF CAGR
—
FCF margin
-18.7%
FCF / Net income
-124.71x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $537.1M · net income $804000.0 · FCF $-100.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $537.1M | $537.1M | $495.6M | $472.4M | $459.8M |
| Net Income | $804000.00 | $804000.00 | $7.4M | $29.1M | $40.8M |
| EBITDA | $45.5M | $45.5M | $47.4M | $78.4M | $87.3M |
| EPS | 0.04 | 0.04 | 0.36 | 1.40 | 1.96 |
| Gross Margin | 48.7% | 48.7% | 49.8% | 49.6% | 50.6% |
| Operating Margin | -0.7% | -0.7% | 0.9% | 6.2% | 10.2% |
| Net Margin | 0.1% | 0.1% | 1.5% | 6.2% | 8.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.26 | 0.26 | 0.06 | 0.02 | 0.01 |
| Cash Flow | |||||
| Free Cash Flow | $-100.3M | $-100.3M | $-21.3M | $403000.00 | $12.9M |
| Returns | |||||
| ROE | 0.1% | 0.1% | 1.2% | 4.9% | 7.1% |
| Valuation | |||||
| P/E | 348.97 | 348.97 | 188.75 | 43.96 | 32.73 |
| EV/EBITDA | 50.82 | 50.82 | 29.71 | 16.13 | 14.95 |
| P/B | 3.62 | 3.62 | 2.33 | 2.15 | 2.32 |
| Growth & Yield | |||||
| Revenue Growth | 8.4% | 8.4% | 4.9% | 2.7% | — |
| EPS Growth | -88.9% | -88.9% | -74.3% | -28.6% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
521.4%
EPS terminal req.
$9.60
Spread vs growth
-610.3%
5Y implied EPS CAGR
210.9%
EPS terminal req.
$11.61
Spread vs growth
-299.8%
10Y implied EPS CAGR
84.9%
EPS terminal req.
$18.71
Spread vs growth
-173.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+48.3%
Start / end P/E
203.4x → 2714.2x
EPS bridge
0.36 → 0.04
Residual
-1097.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.